Aethlon Medical (AEMD) Return on Capital Employed (2016 - 2024)
Aethlon Medical (AEMD) has disclosed Return on Capital Employed for 13 consecutive years, with 1.66% as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Return on Capital Employed fell 34.0% year-over-year to 1.66%, compared with a TTM value of 1.66% through Dec 2024, down 34.0%, and an annual FY2024 reading of 1.14%, down 44.0% over the prior year.
- Return on Capital Employed was 1.66% for Q4 2024 at Aethlon Medical, down from 1.48% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 0.37% in Q3 2021 and bottomed at 1.68% in Q1 2024.
- Average Return on Capital Employed over 5 years is 0.86%, with a median of 0.7% recorded in 2022.
- The sharpest move saw Return on Capital Employed soared 686bps in 2020, then crashed -101bps in 2024.
- Year by year, Return on Capital Employed stood at 0.59% in 2020, then surged by 31bps to 0.41% in 2021, then plummeted by -67bps to 0.68% in 2022, then crashed by -95bps to 1.32% in 2023, then dropped by -25bps to 1.66% in 2024.
- Business Quant data shows Return on Capital Employed for AEMD at 1.66% in Q4 2024, 1.48% in Q3 2024, and 1.54% in Q2 2024.